Influenza Market (H1N1 Vaccines and Others) by Product (Influenza Vaccines and Influenza Drugs): Global Industry Perspective, Comprehensive Analysis and Forecast 2014 - 2020
Deerfield Beach, FL -- (SBWIRE) -- 03/01/2017 -- Zion Research has published a new report titled "Influenza (H1N1 Vaccines and Others) Industry by Product (Influenza Vaccines and Influenza Drugs): Global Market Perspective, Comprehensive Analysis and Forecast, 2014 – 2020." According to the report, the global influenza market was valued at USD 4.27 billion in 2014 and is expected to reach at USD 6.87 billion by 2020, growing at a CAGR of 8.33% between 2015 and 2020.
Influenza infection can affect throat, nose as well as lungs. It's a contagious disease in which three types of viruses includes namely as influenza type A, influenza type B, influenza type C. Seasonal, pandemic and zoonotic or variant are the types of influenza. Trivalent flu vaccines are made to protect against influenza viruses.
Global Influenza Market Forecast, 2014 – 2020
Increasing awareness regarding influenza is one of the major driving factors for global influenza market. Moreover, world health organization (WHO) has also come up with a global action plan for influenza vaccination across the globe. However, influenza market is expected to face major challenge from antigenic drift of influenza viruses. Influenza virus continuously evolves at a rapid pace. Additionally, lack of cold storage facilities presents major challenge for the growth of influenza market.
Click Here For Request Sample Report http://bit.ly/2e8rKRD
H1N1 vaccines accounts for major chunk of influenza market with around 79% share of the total market in 2014. Influenza market is also segmented based on drugs and vaccines. Vaccines dominated the influenza market with over 80% share of the market in 2014. It is also expected to be the fastest growing market segment during the forecast period. On the basis of regions, global influenza market has been segmented as Americas, EMEA (Europe, Middle East and Africa) and Asia Pacific. Americas dominated the global market with around 60% share of the global market in 2014. Americas was followed by EMEA and Asia Pacific respectively.
Some of the key industry participants in global influenza market include AstraZeneca, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis, Sanofi-Pasteur and others. Global influenza market is led by top five companies including AstraZeneca, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis, Sanofi-Pasteur. This five companies accounts for over two third shares of the global market.
Do Inquiry before buying: http://bit.ly/2ej9Tbb
This report segments the global influenza market as follows:
Influenza Market – Product Segment Analysis
Influenza Market – Regional Analysis
EMEA (Europe, Middle East and Africa)
Browse the full "Influenza Market (H1N1 Vaccines and Others) by Product (Influenza Vaccines and Influenza Drugs): Global Industry Perspective, Comprehensive Analysis and Forecast 2014 – 2020" report at http://www.marketresearchstore.com/report/influenza-market-by-product-36077